Virtual Medicinal Product (VMP)
-
Betamethasone 0.1% ear/eye/nose drops
Name Details
Current Name
Betamethasone 0.1% ear/eye/nose drops
|
Start Date
22-01-2003
|
End Date
|
Previous Name
Betamethasone 0.1% ear/eye/nose drops
|
Start Date
15-12-2002
|
End Date
21-01-2003
|
Unit Dose & Form Information
- DF Indicator
- Continuous
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Auricular, Ocular, Nasal
- Form
- Ear/eye/nose drops solution
- Ontology Form/Route
- solutiondrops.auricular, solutiondrops.ophthalmic, solutiondrops.nasal
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
S03BA03
BNF |
Current BNF
11040100
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
12020100
|
Start Date
17-02-2005
|
End Date
03-04-2022
|
Previous BNF
12010100
|
Start Date
16-02-2005
|
End Date
03-04-2022
|
Previous BNF
11040100
|
Start Date
15-02-2005
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
42185411000001109 |
25-08-2023 |
|
354027002 |
15-12-2002 |
24-08-2023 |
VMP Ingredients
Name
Betamethasone sodium phosphate
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
1
Strength and UOM (Dmr)
1
Parent Products
-
VTM
Betamethasone
-
VMP
(Current) Betamethasone 0.1% ear/eye/nose drops
Virtual Medicinal Product Pack (VMPP) Information